Angie Lackenby

род занятий: автор

Серия

There is nothing here

Создать новую серию

Произведения

There is nothing here

Создать новое произведение

Статьи 41

Дата

Заголовок

Авторы

2020-01-28

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017-2018

Larisa Gubareva, Angie Lackenby, Kanta Subbarao, Aeron C. Hurt
2020-07-28

INCREASED RISK OF SARS-CoV-2 INFECTION IN STAFF WORKING ACROSS DIFFERENT CARE HOMES ENCHANCED CoVID-19 OUTBREAK INVESTIGATIONS IN LONDON CARE HOMES

Maria Zambon, Shamez N Ladhani, Angie Lackenby, Karthik Paranthaman
2020-09-09

Investigation of SARS-CoV-2 outbreaks in six care homes in London, April 2020

Angie Lackenby, Karthik Paranthaman
2020-11-01

Do point-of-care tests (POCTs) offer a new paradigm for the management of patients with influenza?

Angie Lackenby
2019-11-01

End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19

Хизер Уитакер, Jim McMenamin, Matthew Donati, Maria Zambon, Angie Lackenby, Nick Andrews, Rory Gunson
2019-11-09

Transmitted and acquired oseltamivir resistance during the 2018-2019 influenza season

Angie Lackenby
2019-08-01

End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18

Diogo Marques, Catherine Moore, Maria Zambon, Angie Lackenby, Nick Andrews
2018-09

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017

Alicia M Fry, Takato Odagiri, Larisa Gubareva, Angie Lackenby, Aeron C. Hurt
2018-10-23

The mechanism of resistance to favipiravir in influenza

Daniel Goldhill, Wendy Barclay, Aartjan J W te Velthuis, Maria Zambon, Angie Lackenby
2018-10-31

Determining the Mutation Bias of Favipiravir in Influenza Using Next-generation Sequencing

Daniel Goldhill, Wendy Barclay, Paul Kellam, Maria Zambon, Angie Lackenby
2018-07-23

Determining the Mutation Bias of Favipiravir in Influenza Using Next-generation Sequencing

Daniel Goldhill, Wendy Barclay, Paul Kellam, Maria Zambon, Angie Lackenby
2017-08-09

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016.

Aeron C. Hurt, Emi Takashita, Patricia A Jorquera, Helena Rebelo-de-Andrade, Alicia M Fry, Takato Odagiri, Larisa Gubareva, Angie Lackenby
2017-08-10

Early seasonal influenza vaccination and delayed influenza peaks - A possible cause of end-of-season outbreaks.

Angie Lackenby
2016-07-19

Contact transmission of influenza virus between ferrets imposes a looser bottleneck than respiratory droplet transmission allowing propagation of antiviral resistance

Jonathan W Ashcroft, Konrad C Bradley, Wendy Barclay, Neeltje van Doremalen, Christl Ann Donnelly, Angie Lackenby
2016-07-30

Late Ebola virus relapse causing meningoencephalitis: a case report

Joseph Hughes, Massimo Palmarini, Duncan Porter, Drosos E. Karageorgopoulos, Susan Hopkins, Kate Templeton, Vattipally B Sreenu, Emma C Thomson, Maria Zambon, Angie Lackenby, Richard J Orton, Gavin S Wilkie, Stephen Mepham, Michael Jacobs
2016-06-02

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.

Helena Rebelo-de-Andrade, Sebastian Maurer-Stroh, Aeron C. Hurt, Larisa Gubareva, Alicia M Fry, Angie Lackenby, Terry G Besselaar, Rod Daniels, Burcu Ermetal, Weijuan Huang, Raphael Tze Chuen Lee, Janice Lo, Ha T Nguyen, Dmitriy Pereyaslov, Marilda Agudo Mendonça Teixeira de Siqueira, Emi Takashita, Masato Tashiro, Danielle Tilmanis, Dayan Wang, Wenqing Zhang, Adam Meijer
2015-12-24

NB protein does not affect influenza B virus replication in vitro and is not required for replication in or transmission between ferrets

Jonathan W Ashcroft, Konrad C Bradley, Wendy Barclay, Angie Lackenby
2015-02-23

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014.

Emi Takashita, Helena Rebelo-de-Andrade, Aeron C. Hurt, Larisa Gubareva, Alicia M Fry, Angie Lackenby, Terry G Besselaar, Rod Daniels, Weijuan Huang, Janice Lo, Dmitriy Pereyaslov, Marilda Agudo Mendonça Teixeira de Siqueira, Masato Tashiro, Dayan Wang, Wenqing Zhang, Adam Meijer
2014-07-17

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013.

Vanessa Correia, Helena Rebelo-de-Andrade, Aeron C. Hurt, Larisa Gubareva, Alicia M Fry, Takato Odagiri, Angie Lackenby, Terry G Besselaar, Rod Daniels, Janice Lo, Dmitriy Pereyaslov, Marilda Agudo Mendonça Teixeira de Siqueira, Emi Takashita, Masato Tashiro, Dayan Wang, Wenqing Zhang, Adam Meijer
2014-03-14

Risk factors for fatality in Panton-Valentine leukocidin-producing Staphylococcus aureus pneumonia cases, England, 2012-2013.

Theresa L Lamagni, Richard Pebody, Hongxin Zhao, Iro Evlampidou, Gavin Dabrera, Angie Lackenby, Angela Kearns, Bruno Pichon
2013-06-12

Virological self-sampling to monitor influenza antiviral susceptibility in a community cohort

Maria Zambon, Angie Lackenby, Nick Andrews
2013-01-31

Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe.

Vincent Enouf, F Pozo, Bruno Lina, Angie Lackenby, Rod Daniels, Adam Meijer
2011-01-01

Evidence of person-to-person transmission of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus in a hematology unit

Catherine Moore, Tamer Abdelrahman, Angie Lackenby
2011-04-14

Evaluation of the antiviral drug susceptibility of influenza viruses in Italy from 2004/05 to 2009/10 epidemics and from the recent 2009 pandemic

Maria Zambon, Angie Lackenby
2011-10-01

Oseltamivir-resistant pandemic (H1N1) 2009 virus infection in England and Scotland, 2009-2010.

Richard Pebody, Jim McMenamin, Maria Zambon, Angie Lackenby
2011-12-18

Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives

Aeron C. Hurt, David Shu-cheong Hui, Timothy M. Uyeki, Alicia M Fry, Frederick G Hayden, Maria Zambon, Larisa Gubareva, Angie Lackenby, Nancy Cox, Rod Daniels, Masato Tashiro, Adam Meijer
2011-10-12

Clinical and socioeconomic impact of different types and subtypes of seasonal influenza viruses in children during influenza seasons 2007/2008 and 2008/2009.

Emilio F Fossali, Susanna Esposito, Nicola Principi, Angie Lackenby, Cristina Daleno, Claudio Giuseppe Molteni, Carlo Giaquinto, Antonia Valzano, Valerio Cecinati, Liviana Da Dalt, Eugenia Bruzzese
2010-03-23

Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection

Nicola Principi, Angie Lackenby, Susanna Esposito
2010-12-16

Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness

Wendy Barclay, Angie Lackenby
2010-04-21

Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment?

Angie Lackenby
2010-08-26

Clinical importance and impact on the households of oseltamivir-resistant seasonal A/H1N1 influenza virus in healthy children in Italy

Nicola Principi, Angie Lackenby, Susanna Esposito, Carlo Giaquinto
2010-01-18

Antiviral drug profile of seasonal influenza viruses circulating in Portugal from 2004/2005 to 2008/2009 winter seasons

Maria Zambon, Angie Lackenby

Human - wd:Q104774735

Добро пожаловать в Inventaire

the library of your friends and communities

узнать больше